During the past decade, Partners in Primary Care conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Partners in Primary Care" #1 collaborator was "Sucampo Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Partners in Primary Care" are "Blood Pressure, High" (1 trials), "Chronic Pain" (1 trials), "Hypertension" (1 trials), "Lower Back Pain" (1 trials) and "Opioid-Induced Bowel Dysfunction" (1 trials). Many other conditions were trialed in "Partners in Primary Care" in a lesser frequency.

Most popular intervention types in "Partners in Primary Care" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "ALO-01 (Morphine Sulfate Plus Naltrexone Hydrochloride Extended Release)" (1 trials), "Carisoprodol SR" (1 trials), "Diclofenac, topical" (1 trials) and "Lubiprostone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Partners in Primary Care" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Partners in Primary Care". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Partners in Primary Care, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Partners in Primary Care, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".